The Oncology Institute, Inc. (STLN) — Cash Flow Reinvestment Rate
Latest as of June 2026:
0.08x
The Oncology Institute, Inc. (STLN) has a Cash Flow Reinvestment Rate of 0.08x as of June 2026, reinvesting $908.00K (capex $908.00K ) from operating cash flow of $11.94 Million. See The Oncology Institute, Inc. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
0.08x
(Capex + Investments) / Operating CF
Total Reinvested
$908.00K
Capex + Investments
Operating Cash Flow
$11.94 Million
USD
Capital Expenditures
$908.00K
USD
Annual Cash Flow Reinvestment Rate for The Oncology Institute, Inc. (None–None)
Year-by-year capital reinvestment analysis for The Oncology Institute, Inc.. For the full cash flow conversion analysis, see The Oncology Institute, Inc. (STLN) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow